Viewing Study NCT03586661


Ignite Creation Date: 2025-12-24 @ 12:22 PM
Ignite Modification Date: 2025-12-29 @ 5:51 PM
Study NCT ID: NCT03586661
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-30
First Post: 2018-07-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module